Pharma work is HCP driven, sample regulated, formulary aware, and FDA compliant. Strkr ships a CRM shaped around HCP engagement, sample management with PDMA signature capture, formulary tracking, and medical science liaison workflow with HIPAA posture and audit-ready records.
A general CRM treats healthcare providers like sales leads with a conversion funnel. Pharma work is HCP engagement with regulated sample distribution, formulary coverage tracking, MSL scientific exchange, and FDA MDUFA, OPDP, and PDMA compliance threading through the motion. The pain points below are what Strkr onboarding hears on every call with pharma companies running primary care, specialty, oncology, rare disease, and biologics portfolios.
HCP engagement scale
A rep covers 180 HCPs across 42 practice locations.
A pharma rep covers 180 to 400 HCPs across 42 to 120 practice locations. The CRM has to carry the HCP relationship (specialty, patient volume, formulary posture, prescribing history) and the practice context (location, group affiliation, IDN parent) separately. A sales CRM with a flat contact-account model does not scale. Strkr HCP schema separates the physician record from the practice location record with the IDN parent relationship.
Sample management burden
PDMA signature capture, lot tracking, FDA audit.
The Prescription Drug Marketing Act requires signature capture for every sample distributed to an HCP. The signature ties to the sample lot, expiration, delivery date, and quantity. The audit trail runs 2 to 7 years depending on product class. Strkr sample management captures digital signature on the rep tablet, ties to the sample lot, and preserves the FDA audit trail with retention per product class.
Formulary tracking
Which plan covers the product and at what tier.
Formulary status (Tier 1 preferred, Tier 2 non-preferred, Tier 3 specialty, prior authorization required, excluded) varies by payer, state, and plan. HCPs make prescribing decisions based on formulary coverage. The rep walks in without knowing the local formulary posture. Strkr formulary object tracks per-product per-payer per-state formulary status with the quarterly refresh and the HCP visit prep brief.
MSL scientific exchange
Medical science liaison interactions are not sales.
MSL interactions carry different regulatory treatment (scientific exchange, unsolicited medical information response, publication discussion, speaker program) and cannot blend with the commercial rep call. Strkr MSL workflow separates MSL interactions from commercial calls with distinct activity types, interaction categorization, and audit trail for OPDP compliance.
Field complaint and adverse event
The FDA MedWatch window is 15 days.
Adverse event reports require FDA MedWatch filing within 15 days for serious events. A rep who hears a patient complaint from an HCP must capture it, triage it, and route to Pharmacovigilance within the window. Strkr field complaint object captures the complaint on the HCP record, triages against event categories, and routes to Pharmacovigilance with the audit log preserving the chain of custody.
FDA submission posture
Fair balance in every rep-delivered message.
FDA OPDP (Office of Prescription Drug Promotion) regulates every rep message with fair balance (benefit and risk together), on-label scope, and MLR (medical, legal, regulatory) approved content. The rep carries only MLR-approved materials. Strkr content library enforces MLR approval status, version control, and audit trail for OPDP compliance posture.
The pharma schema
Objects shaped like pharma field work.
Strkr ships a tunable pharma schema with HCP, Practice Location, IDN Parent, Sample Distribution, Formulary Record, MSL Interaction, Field Complaint, and MLR Content as first-class objects.
HCP object
NPI, specialty, prescribing history, VIP flag.
An HCP carries NPI (National Provider Identifier), specialty (primary care, cardiology, oncology, neurology, pulmonology, endocrinology, rheumatology, psychiatry), patient volume estimate, prescribing history (where legally accessible), VIP flag, speaker program eligibility, and primary rep assignment. The schema drives the call plan and the HCP visit prep brief.
Practice location object
Address, IDN parent, group affiliation, access.
A practice location carries address, IDN parent (hospital system), group affiliation, access type (open, restricted, no-see), and HCP roster. The location object separates from the HCP so an HCP who practices at three locations surfaces at each with the right access posture.
Sample distribution object
HCP, product, lot, quantity, signature.
Each sample distribution ties to the HCP with product, lot number, expiration date, quantity, delivery date, HCP digital signature (PDMA compliant), and rep signature. The audit log preserves the FDA audit trail with retention per product class.
Formulary record object
Payer, state, plan, tier, prior auth.
A formulary record ties to the product with payer (commercial, Medicare Part D, Medicaid, state exchanges, VA, DoD), state, plan, formulary tier (preferred, non-preferred, specialty, excluded), prior authorization requirement, step therapy requirement, and quantity limit. The quarterly refresh updates from external formulary data providers.
An MSL interaction ties to the HCP with interaction type (scientific exchange, unsolicited medical information response, publication discussion, speaker program selection, advisory board), topic, duration, outcome, and MLR documentation. The MSL interaction stays distinct from commercial rep calls for OPDP compliance.
Field complaint object
Captured on HCP, routed to Pharmacovigilance.
A field complaint ties to the HCP with event description, product and lot context, patient context (de-identified), severity assessment, and Pharmacovigilance routing status. The audit log preserves the chain of custody for FDA MedWatch obligations within the 15-day window for serious events.
MLR content object
Approval status, version, fair balance, scope.
MLR content ties to the product with content type (detail aid, left-behind, email, speaker deck), approval status (approved, in review, expired, retired), version, fair-balance confirmation, on-label scope, and rep-usage audit trail. The content library enforces MLR approval for rep usage.
Rep day in the field
A pharma rep day with Strkr in the loop.
A pharma rep covers 8 to 11 HCP calls per day across 3 to 5 practice locations with sample distribution, formulary conversation, scientific exchange, and administrative capture. The cards below show how Strkr fits the real workflow.
0730 call plan
The days HCPs and the visit prep.
The rep opens Strkr before the first call. The day plan shows the HCP targets with specialty, prior visit summary, formulary status for the product in the target plans, and recent prescribing context. The rep walks into the first office with the context loaded.
0830 to 1700
Call capture on the tablet.
Each HCP call captures to Strkr on the rep tablet with discussion topic, MLR-approved content delivered, sample distribution with PDMA signature, formulary conversation outcome, and next-call plan. The signature capture respects the 21 CFR Part 11 electronic signature requirements.
Formulary question
The HCP asks about Tier placement.
An HCP asks whether the product is covered under the local Blue Cross plan. The rep opens the formulary object on the HCP record and surfaces the current tier, prior authorization requirement, and step therapy context. The rep delivers the answer accurately instead of promising to follow up.
MSL referral
The HCP asks about an off-label use.
An HCP asks about an off-label use case. The rep cannot discuss off-label and routes to the MSL for scientific exchange. Strkr MSL referral workflow captures the HCP, the topic, and the referral. The MSL follows up with the HCP within the 72-hour SLA.
Adverse event capture
The HCP mentions a patient event.
An HCP mentions a patient adverse event. The rep captures the event on the HCP record with event description, product context, patient context (de-identified), and severity assessment. The record routes to Pharmacovigilance within 24 hours. The audit log preserves the chain of custody for MedWatch.
1830 day close
Call capture and expense submission.
At day close the rep reviews the auto-populated call records, confirms sample distribution signatures, and files the day. Strkr AI drafts the followup email to each HCP. The rep sends in batch. Day close drops from 90 minutes of CRM paperwork to roughly 20 minutes.
Strkr AI for pharma field work
The AI jobs that fit pharma selling.
Strkr AI drafts in a clinical, compliance-aware tone with retrieval scope strictly scoped to the HCP and the territory. The AI calls do not train on tenant data. All rep-facing drafts respect MLR approval and OPDP posture.
Call plan draft
The days visit targets with prep.
Strkr AI drafts the days call plan with prioritized HCP targets, prep notes, formulary context, and recommended discussion points from MLR-approved content. The rep reviews before the first call.
Call summary
The post-call narrative.
After each HCP call Strkr AI drafts the call summary with discussion topic, HCP engagement signals, formulary conversation outcome, sample distribution context, and next-call plan. The rep reviews and files.
HCP follow-up email
The post-call thank-you with compliance guardrails.
Strkr AI drafts the post-call thank-you with MLR-approved content references, next-visit plan, and resource links. The draft respects OPDP posture with fair-balance language and on-label scope. The rep reviews and sends.
MSL referral narrative
The handoff from commercial to MSL.
When the rep routes an HCP to MSL Strkr AI drafts the referral narrative with the HCP context, topic, and recommended follow-up. The MSL receives the handoff with the context ready.
Formulary brief
The quarterly formulary refresh for the territory.
Strkr AI drafts the quarterly formulary brief for the territory with changes by payer, state, and plan. The regional manager reviews and distributes to the rep team.
Field complaint narrative
The initial complaint capture for Pharmacovigilance.
When a rep captures an adverse event Strkr AI drafts the initial narrative with event description, product context, patient context (de-identified), and severity assessment. Pharmacovigilance reviews and refines before MedWatch filing within the 15-day window.
Head-to-head
Strkr vs Veeva CRM or IQVIA OCE for pharma.
Most pharma companies run Veeva CRM, IQVIA OCE, or an in-house Salesforce customization. The comparison below is Strkr versus Veeva CRM.
Feature
Strkr
Veeva CRM for pharma
HCP schema with specialty and NPI
Native with practice location separation.
Native.
PDMA signature capture
Digital with 21 CFR Part 11 compliance.
Digital with Part 11.
Formulary tracking by payer, state, plan
Yes with quarterly refresh.
Yes.
MSL interaction workflow
Separated from commercial.
Via Veeva Medical module.
MedWatch adverse event routing
Captured on HCP, routed to PV.
Via complaint module.
MLR content library
Approval status enforced.
Via Veeva Vault PromoMats.
HIPAA BAA
Available on request.
Available.
Monthly cost per seat
$119 Scale with full compliance.
$150 to $225 plus implementation retainer.
How teams use Strkr
Three pharma playbooks.
Pattern A
The 180-rep primary care team moving off Veeva.
A 180-rep primary care team at a top-20 pharma company ran Veeva CRM with heavy customization that broke on every quarterly release. Strkr onboarding ran a 48-business-day migration preserving the HCP schema, the sample management workflow, the MLR content library, and the formulary tracking on Strkr. Monthly spend dropped from $168 per seat to $119 per seat (Scale tier). The quarterly Veeva release upgrade work disappeared, which freed about 180 engineering hours per quarter for other work.
Pattern B
The 42-rep oncology specialty team.
A 42-rep oncology specialty team at a mid-size biotech ran Veeva CRM with a custom oncology module that cost $280,000 to implement and $42,000 per quarter to maintain. Strkr onboarding ran a 32-business-day migration with the oncology-specific HCP schema (academic center flag, treatment protocol context, patient volume by indication) landing as first-class fields. Monthly Veeva maintenance disappeared. The team reported 11 hours per rep per week saved on administrative capture.
Pattern C
The 24-MSL rare disease team.
A 24-MSL rare disease team at a specialty pharma ran Salesforce Health Cloud with ServiceNow for complaint management. The MSL interaction workflow blended awkwardly with commercial sales workflow. Strkr onboarding ran a 24-business-day migration consolidating MSL interactions, scientific exchange, publication discussions, and advisory board management on Strkr with MSL interactions distinct from commercial rep calls for OPDP posture. The compliance team signed off on the OPDP posture in the first quarter after cutover.
Run a pharma field motion on a CRM shaped for HCP engagement.
Book a 30 minute call. We will walk through the HCP schema, the sample management workflow, and the formulary tracking with your product portfolio and territory structure.
Does Strkr integrate with IQVIA, Veeva Nitro, or Komodo Health?
Yes through the standard webhook spec with HMAC signing and the published OpenAPI spec. IQVIA Xponent and NSP data integrates for prescribing history and market context. Komodo Health claims data integrates for patient journey context. Veeva Nitro integrates for commercial analytics. Formulary data integrates from MMIT, Fingertip Formulary, or ICON Managed Markets. For pharma companies with a data vendor the integration spec typically lands in an engineering sprint of two to four weeks.
How does Strkr handle 21 CFR Part 11 electronic signature compliance?
Strkr PDMA signature capture respects 21 CFR Part 11 electronic signature requirements: user identification, timestamp, signature meaning, audit trail integrity, and signature link to the signed record. Sample distribution records capture HCP signature on the rep tablet with the signature tied to the sample lot, product, quantity, and delivery date. The audit log preserves the signature chain of custody with retention per product class (typically 7 years).
What is the HIPAA posture for pharma CRM?
Strkr is HIPAA compliant with a BAA available on request. The pharma company signs the BAA with Strkr before PHI touches the system. The AI retrieval scope limits to non-PHI fields by default (HCP name, specialty, practice location, formulary context) and the admin can tune scope per field. For adverse event records that touch patient PHI (even de-identified) the retrieval scope restricts further. The audit log preserves every record access for HIPAA compliance posture review.
Can Strkr handle the MLR content approval workflow?
Yes through the MLR content object. Each piece of content ties to the product with approval status (approved, in review, expired, retired), version, fair-balance confirmation, on-label scope, and rep-usage audit trail. The content library enforces MLR approval for rep usage. For companies running Veeva Vault PromoMats or similar MLR tools Strkr integrates through the published API with content approval status synced bidirectionally.
What does Strkr cost compared to Veeva CRM?
Strkr runs flat per seat at $29 Starter, $59 Pro, $119 Scale per user per month with a 14-day trial. For a 180-rep team on Scale the monthly spend runs $21,420 for seats plus $49 for AI Enhancement. Veeva CRM pricing varies but typically runs $150 to $225 per user per month plus implementation partner retainer. Strkr sits roughly 40 to 60 percent below Veeva at seat level and avoids the implementation partner retainer. The compound 36-month saving is often 3 to 5 million dollars for a mid-size pharma company.
How does field complaint routing work for FDA MedWatch obligations?
When a rep captures an adverse event on an HCP record the complaint auto-routes to the Pharmacovigilance inbox with the HCP context, product and lot context, patient context (de-identified), and severity assessment preserved. Pharmacovigilance reviews the complaint, confirms the MedWatch classification (serious event requiring 15-day filing, non-serious event requiring periodic reporting), and files with FDA within the required window. The audit log preserves the chain of custody from field capture through MedWatch filing for the FDA inspection posture.
No sales call, no migration consultant, no four-month implementation. Enter your card, get 14 days of the full Pro tier, cancel any time before day 14 with zero charge. Spin up a workspace, import your CSV, and have something useful before lunch.
We use cookies.
Essential cookies keep the site working. If you accept, we also enable Google Analytics
so we can see which pages help and which don't. Reject to opt out entirely. Details in our
Privacy Policy.
